Journal of Surgical Education
Volume 64, Issue 3 , Pages 150-157 , May 2007

Intraoperative Margin Re-Resection for Colorectal Liver Metastases

  • Curtis J. Wray, MD

      Affiliations

    • Department of Surgery and Radiology, University of Cincinnati Medical Center, Cincinnati, Ohio
    • ,
  • Andrew M. Lowy, MD

      Affiliations

    • Department of Surgery and Radiology, University of Cincinnati Medical Center, Cincinnati, Ohio
    • ,
  • Jeffrey B. Matthews, MD

      Affiliations

    • Department of Surgery and Radiology, University of Cincinnati Medical Center, Cincinnati, Ohio
    • ,
  • Laura E. James, MS

      Affiliations

    • Department of Surgery and Radiology, University of Cincinnati Medical Center, Cincinnati, Ohio
    • ,
  • Joshua M. Mammen, MD

      Affiliations

    • Department of Surgery and Radiology, University of Cincinnati Medical Center, Cincinnati, Ohio
    • ,
  • Kyuran A. Choe, MD

      Affiliations

    • Department of Surgery and Radiology, University of Cincinnati Medical Center, Cincinnati, Ohio
    • ,
  • Douglas W. Hanto, MD

      Affiliations

    • Department of Surgery, Division of Transplantation, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
    • ,
  • Syed A. Ahmad, MD

      Affiliations

    • Department of Surgery and Radiology, University of Cincinnati Medical Center, Cincinnati, Ohio
    • Corresponding Author InformationCorrespondence: Inquiries to Syed A. Ahmad, MD, Division of Surgical Oncology, Department of Surgery, University of Cincinnati College of Medicine, 234 Goodman Street ML 0772, Cincinnati, OH 45219; fax: (513) 584-0459

References 

  1. Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2002;235:759–766
  2. de Santibanes E, Lassalle FB, McCormack L, et al. Simultaneous colorectal and hepatic resections for colorectal cancer: postoperative and longterm outcomes. J Am Coll Surg. 2002;195:196–202
  3. Bozzetti F, Cozzaglio L, Boracchi P, et al. Comparing surgical resection of limited hepatic metastases from colorectal cancer to non-operative treatment. Eur J Surg Oncol. 1993;19:162–167
  4. Fiorentini G, Poddie DB, De Giorgi U, et al. Global approach to hepatic metastases from colorectal cancer: indication and outcome of intra-arterial chemotherapy and other hepatic-directed treatments. Med Oncol. 2000;17:163–173
  5. Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239:818–825discussion 825-827
  6. D’Angelica M, Brennan MF, Fortner JG, et al. Ninety-six five-year survivors after liver resection for metastatic colorectal cancer. J Am Coll Surg. 1997;185:554–559
  7. Doci R, Gennari L, Bignami P, et al. One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg. 1991;78:797–801
  8. Bradley AL, Chapman WC, Wright JK, et al. Surgical experience with hepatic colorectal metastasis. Am Surg. 1999;65:560–566discussion 566-567
  9. Ohlsson B, Stenram U, Tranberg KG. Resection of colorectal liver metastases: 25-year experience. World J Surg. 1998;22:268–276discussion 276-277
  10. Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol. 1997;15:938–946
  11. Parikh AA, Gentner B, Wu TT, et al. Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy. J Gastrointest Surg. 2003;7:1082–1088
  12. Laurent C, Sa Cunha A, Couderc P, et al. Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br J Surg. 2003;90:1131–1136
  13. Holm A, Bradley E, Aldrete JS. Hepatic resection of metastasis from colorectal carcinoma (Morbidity, mortality, and pattern of recurrence). Ann Surg. 1989;209:428–434
  14. Fuhrman GM, Curley SA, Hohn DC, et al. Improved survival after resection of colorectal liver metastases. Ann Surg Oncol. 1995;2:537–541
  15. Elias D, Cavalcanti A, Sabourin JC, et al. Results of 136 curative hepatectomies with a safety margin of less than 10 mm for colorectal metastases. J Surg Oncol. 1998;69:88–93
  16. Wray CJ, Lowy AM, Mathews JB, et al. The significance and clinical factors associated with a subcentimeter resection of colorectal liver metastases. Ann Surg Oncol. 2005;12:374–380
  17. Couinaud C. Liver anatomy: portal (and suprahepatic) or biliary segmentation. Dig Surg. 1999;16:459–467
  18. Scheele J, Stang R, Altendorf-Hofmann A, et al. Resection of colorectal liver metastases. World J Surg. 1995;19(1):59–71
  19. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309–318discussion 318-321
  20. Cady B, Jenkins RL, Steele GD, et al. Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg. 1998;227:566–571
  21. Smidt ML, Wegdam JA, Bremers AJ, et al. Missing evidence for the adequacy of a 1-cm distal margin in resected rectal cancer. Ann Surg Oncol. 2003;10:823–824
  22. Samson PS, Escovidal LA, Yrastorza SG, et al. Re-study of gastric cancer: analysis of outcome. World J Surg. 2002;26:428–433
  23. Blewett CJ, Miller JD, Ramlawi B, et al. Local recurrence after total or subtotal esophagectomy for esophageal cancer. J Exp Clin Cancer Res. 2001;20(1):17–19
  24. Bozzetti F. Principles of surgical radicality in the treatment of gastric cancer. Surg Oncol Clin N Am. 2001;10:833–854
  25. Bradpiece HA, Benjamin IS, Halevy A, Blumgart LH. Major hepatic resection for colorectal liver metastases. Br J Surg. 1987;74:324–326
  26. Casson AG, Darnton SJ, Subramanian S, et al. What is the optimal distal resection margin for esophageal carcinoma?. Ann Thorac Surg. 2000;69(1):205–209
  27. Vauthey JN, Pawlik TM, Abdalla EK, et al. Is extended hepatectomy for hepatobiliary malignancy justified?. Ann Surg. 2004;239:722–730discussion 730-732
  28. Ekberg H, Tranberg KG, Andersson R, et al. Determinants of survival in liver resection for colorectal secondaries. Br J Surg. 1986;73:727–731
  29. Gennari L, Doci R, Bignami P, et al. Surgical treatment of hepatic metastases from colorectal cancer. Ann Surg. 1986;203(1):49–54
  30. Wagner JS, Adson MA, Van Heerden JA, et al. The natural history of hepatic metastases from colorectal cancer (A comparison with resective treatment). Ann Surg. 1984;199:502–508
  31. Pawlik TM, Scoggins CR, Zorzi D, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005;241:715–722discussion 722-724
  32. Fazakas J, Mandli T, Ther G, et al. Evaluation of liver function for hepatic resection. Transplant Proc. 2006;38:798–800
  33. Choi HJ, Jung IK, Kim SS, et al. Proliferating cell nuclear antigen expression and its relationship to malignancy potential in invasive colorectal carcinomas. Dis Colon Rectum. 1997;40(1):51–59
  34. Zorzi D, Mullen JT, Abdalla EK, et al. Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases. J Gastrointest Surg. 2006;10(1):86–94
  35. DeMatteo RP, Palese C, Jarnagin WR, et al. Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. J Gastrointest Surg. 2000;4:178–184
  36. Aloia TA, Zorzi D, Abdalla EK, et al. Two-surgeon technique for hepatic parenchymal transection of the noncirrhotic liver using saline-linked cautery and ultrasonic dissection. Ann Surg. 2005;242:172–177
  37. Wray CJ, Rilo HL, Ahmad SA. Colon cancer angiogenesis and antiangiogenic therapy. Expert Opin Investig Drugs. 2004;13:631–641
  38. Fernando NH, Hurwitz HI. Targeted therapy of colorectal cancer: clinical experience with bevacizumab. Oncologist. 2004;9(Suppl 1):11–18
  39. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350:2335–2342
  40. Ellis LM, Curley SA, Grothey A. Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab. J Clin Oncol. 2005;23:4853–4855
  41. Saif MW. Targeted agents for adjuvant therapy of colon cancer. Clin Colorectal Cancer. 2006;6(1):46–51
  42. Saad ED, Hoff PM. Chemotherapy of Metastatic Colorectal Cancer. Curr Treat Options Gastroenterol. 2005;8:239–247
  43. Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol. 2006;24:2065–2072

PII: S1931-7204(07)00059-1

doi: 10.1016/j.jsurg.2007.03.001

Journal of Surgical Education
Volume 64, Issue 3 , Pages 150-157 , May 2007

Article Tools

* Image Usage & Resolution